Latest Breast cancer Stories
China Food and Drug Administration (CFDA) approves cancer treatment system BEIJING, Dec.
Active Immunotherapy Targets hTERT Gene Associated with 85% of Cancers PLYMOUTH MEETING, Pa., Dec. 18, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
MeVis Would Add Image Processing Software and Services for Detection of Cancer to Varian's Imaging Components Product Portfolio PALO ALTO, Calif., Dec.
Renowned Breast Cancer Radiologist also a Professor, Researcher and Highly-Sought Speaker ORANGE and LOS ANGELES Counties, Calif., Dec.
DALLAS, Dec.15, 2014 /PRNewswire/ -- Dr.
Modest weight loss could dramatically improve a breast cancer patient’s chances of survival, according to new research published earlier this month at the San Antonio Breast Cancer Symposium.
Positive Results of Largest Genomic Study in DCIS Reconfirm Oncotype DX is a Strong, Independent Predictor of Local Recurrence SAN ANTONIO, Dec.
SAN DIEGO, Dec. 12, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc.
Breast cancer is scary. Its prevalence certainly should make all women aware and active in preventing, catching it early, and taking an active role in treatment. And even though women should have a voice in their treatment, often they simply follow the guidelines set out by their doctors.
-- Findings Presented at 2014 San Antonio Breast Cancer Symposium (SABCS) -- SAN ANTONIO and SAN FRANCISCO, Dec.
Clinical Breast Cancer is a peer-reviewed medical journal established in 2000 and published bimonthly by Elsevier. As of May 2012, the editor-in-chief is George W. Sledge, Jr. The journal publishes original articles describing various aspects of clinical and translational research of breast cancer. It is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer....
Breast Cancer Research and Treatment is a peer-reviewed scientific journal published by Springer Verlag. It focuses on the treatment of and investigations in breast cancer. The journal is targeted towards a wide audience of clinical researchers, epidemiologists, immunologists, and cell biologists whom are interested in breast cancer. Articles in this journal include: original research, invited reviews, discussions on controversial issues, book reviews, meeting reports, letters to the editors,...
- A political dynamiter.
More Images (2 images) »